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The epidemiology of subclavian artery calcification
Anand Prasad, MD,a Christina L. Wassel, PhD,b Nicole E. Jensky, PhDb and
Matthew A. Allison, MD, MPH,b San Diego, Calif
Objectives: The purpose of the present study was to determine the prevalence and risk factor associations for subclavian
artery calcification.
Background: Arterial calcification is a marker of atherosclerosis, and its presence portends an adverse prognostic risk. The
prevalence and associated risk factors for aortic arch, carotid, renal, and coronary calcification have been well described.
Fewer data are available for subclavian artery calcification.
Methods: Electron-beam computed tomography was used to evaluate the extent of vascular calcification in multiple arterial
beds in 1387 consecutive individuals who presented for preventive medicine services at a university-affiliated disease
prevention center. Laboratory values for blood pressure, lipids, anthropomorphic data, and self-reported medical history
were obtained.
Results: Subclavian artery calcification was present in 439 of 1387 individuals (31.7%). Those with subclavian artery
calcification were significantly older, had a smaller body mass index, and were more likely to also have calcification of
nonsubclavian vascular beds. When adjusted for cardiovascular disease risk factors, the presence of subclavian artery
calcification was significantly associated with age (prevalence ratio [PR], 1.04; P < .001), hypertension (PR, 1.20; P 
.01), history of smoking (PR, 1.21; P  .01), and calcification in nonsubclavian vascular beds (PR, 1.58; P  .01).
Subclavian artery calcification was also associated with an increased pulse pressure (-coefficient  2.2, P  .008).
Conclusions: Subclavian artery calcification is relatively common and is significantly associated with age, smoking, hyperten-
sion, and nonsubclavian vascular calcification. There may be a relationship between vascular stiffness, as manifested by a



























wArterial calcification represents the culmination of a
complex series of molecular and pathophysiologic mecha-
nisms.1,2 Calcification associated with atherosclerosis has
an important relationship to overall cardiovascular risk.
Specifically, the detection of calcium in different arterial
beds, including the coronary circulation, carotid and renal
arteries, and the thoracic and abdominal aorta, has been
associated with a variety of cardiovascular risk factors and
with an adverse prognosis.3-5 Moreover, calcification of the
aortic arch is an independent risk factor for coronary heart
disease (CHD).6,7 Because the subclavian arteries are rela-
tively close to the aortic arch, examination of the presence
and extent of subclavian artery calcification (SAC) would
expand current knowledge about the distribution of ath-
erosclerosis in the major vessels. Notably, risk factors for
SAC have not been previously described.
The present study was conducted to determine the
prevalence and risk factor associations for SAC.We hypoth-
esized that risk factors and disease associations for calcifica-
tion of the subclavian vessels would be similar to that
described in the literature for aortic and carotid calcifica-
From the Department of Medicine, Division of Cardiology,a and the De-
partment of Family and Preventive Medicine, Division of Preventive
Medicine,b University of California, San Diego.
This research was supported in part by a grant from the American Heart
Association to Dr Allison.
Competition of interest: none.
Corresponding author: Matthew A. Allison, MD, MPH, 9500 Gilman Dr,
MC 0965, La Jolla, CA 92093-0965 (e-mail: mallison@ucsd.edu).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00r
Copyright © 2011 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2011.04.055
1408ion. Specifically, we hypothesized that aging, diabetes, and
history of hypertension would be related to the presence
f SAC.
ETHODS
The protocol for this study was approved by the Hu-
an Research Protection Program at the University of
alifornia, San Diego, which granted a waiver of informed
onsent to conduct this retrospective analysis of existing
linical data.
Participants. From February 1, 2001, to June 29,
001, 1387 consecutive individuals presented for preven-
ive medicine services at a university-affiliated disease pre-
ention center in San Diego, California, and had complete
ata available for the current analysis. Most patients were
elf-referred or referred from local physicians to obtain
etailed preventive health information and testing.
Participants completed a detailed health history ques-
ionnaire that collected information on history of hyperten-
ion, diabetes, high cholesterol, smoking, medications,
amily history of CHD, diet, exercise, and prior operations.
ll individuals underwent whole-body electron-beam com-
uted tomography (CT) imaging and were evaluated for
he extent of vascular calcification in the coronary, subcla-
ian, thoracic aorta, renal, abdominal aorta, and iliac ves-
els. Data on a subgroup of these individuals have been
reviously reported.5,8
Laboratory measurements. Casual serum levels of
otal, high-density (HDL), and low-density (LDL) choles-
erol, and glucose measurements were obtained by finger-
tick using the Cholestech LDX system (Cholestech, Hay-
ard, Calif). Individuals with a total/HDL cholesterol
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Volume 54, Number 5 Prasad et al 1409cholesterol were classified as dyslipidemic. Diabetes was
defined by current use of prescribed antiglycemic medica-
tions or a random glucose level 200 mg/dL.
Blood pressure. Blood pressure was measured after
the participants had rested for 5 minutes while seated.
Trained individuals obtained systolic (SBP) and diastolic
(DBP) blood pressures in the right arm by automated
oscillometry. Mean arterial pressure (MAP) was calculated
using the following equation: MAP  DBP  1/3 
(SBP – DBP). Pulse pressure was the difference between
SBP andDBP.Hypertension was defined as an SBP orDBP
140 or 90 mmHg, respectively, or a self-reported history
of physician-diagnosed hypertension and current use of an
antihypertensive medication.
Imaging. Data on the imaging techniques used for
these individuals have been previously described in detail.8
Briefly, imaging was conducted using an Imatron C-150
scanner (General Electric, San Francisco, Calif). Images for
each vascular bed (carotid, subclavian, aorta, coronaries,
renals, and iliac) were obtained from a single scan and
proceeded caudally from the base of the skull to the sym-
physis pubis. Each bedwas obtained by a distinct scan of the
segment in question by using slice thicknesses of 3 mm for
the coronary bed, 5 mm for the thorax, and 6 mm through
the neck, abdomen, and pelvis. Imaging of the heart,
thorax, and abdomen was conducted during separate
breath holds at 50% maximal inspiration.
Quantitative calcium scores were determined accord-
ing to the method described by Agatston et al.9 Atheroscle-
rotic calcium was defined as a plaque area 1 mm2 with a
density of 130 Hounsfield units. The total calcium score
was determined by summing the lesion scores from all of
the slices for that segment. The degree of subclavian calci-
fication was derived by grouping the calcium scores for the
right subclavian, innominate, and left subclavian arteries.
The right subclavian artery was identified from the root of
the aorta as the brachiocephalic, and subsequent subcla-
vian, artery. The left subclavian was identified from the root
of the aorta. Both arteries were examined through the
mediastinum to where they arched over the top of the lung.
Statistical analysis. Baseline characteristics were com-
pared within gender for SAC using analysis of variance, 2,
or Kruskal-Wallis tests, as appropriate. SAC was examined
as a dichotomous outcome (yes/no) and as a continuous
outcome among those with any subclavian calcium. In this
study, the prevalence of SAC was 10%. Because odds
ratios from logistic regression will overestimate the preva-
lence ratios in this case, log-binomial models were used to
assess associations of risk factors with SAC0 vs SAC 0.
If issues with convergence of the log-binomial models were
encountered, a Gaussian link with robust standard errors
was used. Because SAC scores0 were skewed, these were
natural log-transformed, and linear regression was used to
assess the association of risk factors with these outcomes. In
models examining the association of SAC with blood pres-
sure measures, linear regression was also used. For these
models, univariate associations of SAC with each blood
pressure outcome were evaluated first, and then staged podels were used to examine potential confounders. Tra-
itional cardiovascular risk factors and variables that have
een associated with subclinical atherosclerosis in our pre-
ious studies were included in the regression models, in-
luding age, sex, body composition, smoking, diabetes,
ypertension, family history of CHD, dyslipidemia, and
onsubclavian calcification. SAS 9.1.3 software (SAS Insti-
ute, Cary, NC) was used for statistical analysis.
ESULTS
Prevalence of SAC. SAC was found in 439 of 1387
articipants (31.7%). Individuals with SAC were older than
hose without SAC (63 11 vs 54 11 years, respectively;
 .001). The characteristics of the study cohort and the
resence of SAC adjusted for age and sex are reported in
able I. Those with SAC had a slightly smaller body mass
ndex (26  6 vs 27  4 kg/m2, P  .001) and less
ercentage of body fat (28.7% vs 30.1%, P  .001) vs
ndividuals without SAC. The prevalence of hypertension
y history was no different in participants with SAC vs those
ithout SAC. Although the two groups had similar SBPs,
hose with SAC had lower DBP (79  11 vs 81  11 mm
g, P .02). The prevalence of arterial calcification in the
arotid, coronary, renal, iliac arteries, and total aortic vas-
ular beds was 24.6%, 60.3%, 18.2%, 58.9%, and 62.5%,
espectively. Calcification in the nonsubclavian vascular
eds was significantly more common in those with SAC
P  .001 for the carotids, coronaries, renal arteries, and
liac arteries; P  .002 for the total aorta; Fig).
Multivariable risk factor analysis for SAC. In a
ultivariable logistic regression model containing age,
ody mass index, body fat, sex, former or current smok-
ng, hypertension, diabetes, family history of CHD, dys-
ipidemia, and calcium presence in the nonsubclavian
ascular beds (Table II), the presence of SAC was signif-
cantly associated with age (prevalence ratio [PR], 1.04
er year, 95% confidence interval [CI], 1.03-1.04;
 .001), BMI (PR, 0.97; 95% CI, 0.95-1.00; P .02), a
istory of smoking (PR. 1.21; 95%CI, 1.04-1.40; P .01),
ypertension (PR, 1.20; 95% CI, 1.04-1.39; P .01), and
alcification in other vascular beds, including carotid, cor-
nary, aortic, renal, or iliac arteries (PR, 1.58; 95% CI,
.11-2.25; P  .01). For the individual vascular beds, the
resence of SAC was associated with calcification of the
arotids (PR, 1.36; 95% CI, 1.16-1.60; P  .001), aorta
PR, 1.40; 95% CI, 1.05-1.86; P  .02), renal (PR, 1.60;
5% CI, 1.35-1.88; P  .001), and coronary arteries (PR
.27; 95% CI, 1.00-1.61; P  .05). The association with
iabetes was of borderline significance (PR 1.25; 95% CI,
.98-1.60; P  .07).
Using the same modeling strategy, the amount of SAC
as associated with age (% difference in SAC, 6.0%; 95%CI,
.6-7.3; P  .001), a history of smoking (26.7%; 95% CI,
.5.5-60; P  .04), hypertension (66.1%; 95% CI, 30.7-
11.2; P  .001), carotid calcification (77.8%; 95% CI
7.4-130.1; P  .001), renal artery calcification (63.8%;
5% CI 25.9-112.9; P  .001), and coronary calcium
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blood pressure. After adjustment for age, sex, and cardiovas-
cular risk factors (except hypertension), the presence of SACwas




Age, yearsc 57  11
Female sexc 609 (43.9)
Current smoker 122 (8.8)
BMI, kg/m2 27  5
Percent body fat, % 30  8
Blood pressure, mm Hg
Systolic 126  16
Diastolic 80  11
Cholesterol, mg/dL
Total 201  40
HDL 53  18
Dyslipidemiad 293 (21.1)
Glucose, mg/dL 107  34
Family history of CHD 352 (25.4)
History of CABG 10 (0.7)
History of PCI 19 (1.4)
Prevalent hypertension 558 (40.2)
Prevalent diabetes 63 (4.5)
CABG, Coronary artery bypass grafting; CHD, coronary heart disease; H
subclavian artery calcification.
aContinuous data are presented as mean  standard deviation, and categori
bBy t test, Wilcoxon, or 2 test, as appropriate.
cUnadjusted data for age and % male, not applicable.
dTotal cholesterol/HDL cholesterol ratio 5.0.
Fig. Association of subclavian artery calcification (SAC) w
adjusted for age and sex. The presence of any calcification in
of SAC. P  .001 for the comparison of calcification of th
individuals with and without SAC. P .002 for the total aassociated with SBP (-coefficient  2.0, P  .05) and pulse mressure (PP;-coefficient2.2,P .008;Table III). After the
ame adjustments, the amount of SACwasmost strongly associ-
ted with decreasing DBP (-coefficient –1.2, P .04) and
Adjusted for age and sex
SAC present SAC absent
Pb(n  439) (n  948)
63  11 54  11 .001
176 (40.0) 433 (45.7) .06
54 (12.3) 68 (7.2) .003
26  6 27  4 .001
29  6 30  6 .001
127  16 126  16 .73
79  11 81  11 .02
200  41 201  40 .39
53  16 52  15 .31
86 (19.7) 207 (21.8) .37
108  35 107  34 .52
121 (27.6) 231 (24.4) .23
6 (1.3) 4 (0.45) .10
1 (0.22) 18 (0.97) .08
189 (43.1) 369 (38.9) .15
24 (5.4) 39 (4.1) .30
igh-density lipoprotein; PCI, percutaneous coronary intervention; SAC,
are presented as or number (%).
e prevalence of calcification in other arterial beds is shown
vascular beds has been stratified by the presence or absence
tid, coronary, total aortic, renal arterial, and iliac beds in
calcification in subjects with and without SAC.DL, h
c dataith th
other
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In this study of a relatively large cohort of individuals
with a low frequency of established cardiovascular disease
(CVD), atherosclerotic calcification was found in the sub-
clavian arteries of nearly one-third of the patients. Of the
traditional CVD risk factors, age, a history of smoking, and
a history of hypertension were independently associated
with the presence and amount of SAC. In addition, ele-
vated SBP, a widened PP, and extrasubclavian vascular bed
calcification also appear to be related to the presence of
SAC. The amount of SAC was significantly associated with
age, lower DBP, a history of smoking, and a history of
hypertension.
Prevalence of SAC and comparison with calcifica-
tion of other vascular beds. Numerous studies have ex-
Table II. Multivariate models for the presence and extent
Variable
SAC presence (n  1387)
PR (95% CI)
Age, per 1 year 1.04 (1.03-1.04)
BMI, per 1 unit 0.97 (0.95-1.00)
Body fat, per 1% 1.00 (0.98-1.01)
Female sex 0.87 (0.71-1.06)
History of smokingc 1.21 (1.04-1.40)
Hypertension 1.20 (1.04-1.39)
Diabetes 1.25 (0.98-1.60)
Family history CHD 1.03 (0.88-1.20)
Dyslipidemia 1.03 (0.86-1.23)
Presence of
Any calciumd 1.58 (1.11-2.25)
Carotid calcium 1.36 (1.16,1.60)
Iliac calcium 1.22 (0.96,1.55)
Aortic calcium 1.40 (1.05-1.86)
Renal artery calcium 1.60 (1.35-1.88)
Coronary calcium 1.27 (1.00-1.61)
CHD, Coronary heart disease; CI, confidence interval; PR, prevalence ratio
aSAC presence defined as Agatston score 0.
bThose with Agatston score 0 only – % difference in SAC (100  [e-coeffi
cCurrent or former smoking.
dPresence in any other nonsubclavian vascular bed, including carotid, iliac,





 (95% CI)  (95%
Presence
Unadjusted 3.3 (1.3-5.4) .001 –1.3 (–2.6
Age/sex 0.4 (–1.7 to 2.6) .69 –1.6 (–3.0
CHD risk factorsa 2.0 (–0.02 to 3.9) .05 –0.6 (–1.9
Amountb
Unadjusted 2.4 (1.2-3.5) .001 –0.9 (–2.0
Age/sex 0.7 (–0.7 to 2.0) .35 –1.2 (–2.4
CHD risk factorsa 0.2 (–1.1 to 1.6) .73 –1.2 (–2.3
CHD, Coronary heart disease; CI, confidence interval; DBP, diastolic bloo
pressure.
aBody mass index, body fat, diabetes, smoking, dyslipidemia, family history
bModeled per standard deviation (SD) where SD  159.6 for DBP and MAamined the prevalence of coronary artery calcification in the aeneral population.10-13 The presence of coronary calcifi-
ation is a marker for subclinical atherosclerosis, and the
egree of calcification may provide important prognostic
nformation, even in asymptomatic individuals.14 Compar-
tively fewer studies have examined the prevalence and
redictive value of peripheral vascular calcification. Our
roup has previously reported the frequency of renal artery
alcification derived from a cohort similar to the one in the
resent study.8 The prevalence of renal artery calcification
as 18%, and evidence of renal artery calcification was
ignificantly associated with age, male sex, hypertension,
nd calcification in other beds.
A larger body of data describes the epidemiology of aortic
rch and carotid calcification.3,7 Given that the left and right
as a continuation of the innominate artery) subclavian arteries
bclavian artery calcification (SAC)
SAC extent (n  439)b
% Difference in SAC (95% CI) P
1 6.0 (4.6-7.3) .001
2.7 (–1.5 to 7.2) .21
	1.7 (–4.3 to 0.84) .18
	13.7 (–40.4 to 24.9) .43
26.7 (0.55-60) .04
66.1 (30.7-111.2) .001
	7.3 (–42.5 to 49.6) .76
	6.5 (–28 to 21.4) .61
8.2 (–19.6 to 45.7) .6
43.9 (–9.8 to 129.5) .13
1 77.8 (37.4-130.1) .001
25.4 (–10.1 to 74.9) .18
16.2 (–20.6 to 70.1) .44
1 63.8 (25.9-112.9) .001
36.3 (0.21-85.3) .05
1]).
renal, or coronary arteries.





P (95% CI)  (95% CI)
01) .06 4.5 (2.9-6.1) .001 0.2 (–1.2 to 1.6) .76
.2) .03 1.7 (0.6-3.3) .04 –1.0 (–2.5 to 0.4) .17
8) .42 2.2 (0.6-3.8) .008 0.2 (–1.2 to 1.5) .81
1) .07 2.4 (1.4-3.3) .001 –0.3 (–1.4 to 0.8) .65
.1) .03 0.9 (–0.2 to 2.0) .1 –1.0 (–2.2 to 0.1) .08
.1) .04 0.8 (–0.4 to 1.8) .18 –1.0 (–2.2 to 0.1) .08
sure; MAP, mean arterial pressure; PP, pulse pressure; SBP, systolic blood
D.
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Aortic arch calcification has been studied extensively and
appears to be more common than coronary calcification.15
Using radiographic evidence of calcification in a large popu-
lation-based sample of116,000 individuals, Iribarren et al3
demonstrated a 1.9% occurrence of aortic arch calcification
in men and 2.6% in women, with independent associations
with age, smoking, and hypertension. The prevalence in
those aged 65 years was 11% in men and 16% in women.
Furthermore, arch calcification was related to CVD out-
comes, specifically to the risk of coronary artery disease in
men and stroke in women. Although not directly compa-
rable to the isolated aortic arch, our own group, using
data derived from electron-beamCT demonstrated a prev-
alence of thoracic aortic calcification of 63% to 69%
(women, men, respectively) in 60 to 70 year olds and in
96% to 98% in those aged70 years.15 Furthermore, these
data confirmed the previously described risk factor associa-
tions, specifically, the strong association of age and hyper-
tension with calcification of the aorta.
Calcification of the carotid arteries has also been an area
of extensive research. In this regard, calcific plaque involv-
ing the common or internal carotid artery, or both, is an
adverse predictor of cardiovascular events. Prabhakaran et
al16 examined the prevalence and prognostic significance of
carotid calcification by vascular ultrasound in a stroke-free
cohort of seniors and noted a 20.1% prevalence of carotid
artery calcification. Calcified plaque was associated with
age, diabetes, hyperlipidemia, and coronary disease, and at
a follow-up of almost 3 years, calcified plaque (vs noncalci-
fied or no plaque) was independently associated with the
highest likelihood of vascular death, myocardial infarction,
or stroke. Using more sensitive methods, Odink et al6
examined CT-derived Agatston scores in a senior popula-
tion sample and noted the presence of calcification in 83%
of men and 77% of women. Within this senior cohort,
increasing calcification was associated with increasing age.
Our group’s analysis of the pattern of calcification in a
wider age range cohort demonstrated the importance of
age as a risk factor for the presence of carotid calcification.15
The prevalence of carotid calcification in the 60 to 70 age
range was 26% to 30% in women and 42% to 45% in men.
Smoking and hypertension were also strongly associated
with carotid calcification in men but less so in women.
The data from the present study demonstrate that
similar to the carotid circulation, age, smoking, and hyper-
tension were important risk factors for the presence of SAC.
Furthermore, the presence and extent of SAC appeared to
be related to carotid artery calcification. The similarities in
anatomic location of the great vessels from the arch may
subject these vessels to similar aging- and hypertension-
related changes in vascular stiffness and hemodynamic flow
disturbances.
Role of vascular stiffness in SAC. In the present
study, a history of hypertension, the presence of an elevated
SBP, and a widening of the PP were associated with the
presence of SAC. A decrease in DBP also appeared to be
associated with the amount of SAC present. These data Cuggest that increasing vascular stiffness, as reflected by
ystemic pressure measurements, may be related to SAC.
he degree of vascular stiffness is strongly associated with
ging and the presence of hypertension.17,18 Our group
reviously noted an independent association between wid-
ning of the PP and increasing SBP with the presence of
rterial calcification in the carotid and coronary arteries and
n the thoracic and abdominal aortas. These relationships
ere much stronger in those aged 60 vs those aged 60
ears.19 Furthermore, other investigators have demon-
trated that increasing aortic stiffness, as measured by pulse
ave velocity analysis, and decreasing carotid distensibility
ave both been correlated with increasing calcification of
he aortic arch and carotid arteries, respectively.20 Calcifi-
ation of the subclavian and carotid vessels may create
eflection sites that augment the PP difference in older
ndividuals. This process likely represents concurrent mech-
nisms that may be additive to one another and related to a
omplex interplay between vascular remodeling, inflamma-
ion, and atherosclerotic plaque deposition. Additional
tudies will need to be performed to determine if SAC is
elated to more specific measures of vascular stiffness.
Study limitations. In the present study, blood pres-
ures were not obtained in both arms; therefore, the prev-
lence of subclavian artery stenosis in conjunction with
AC cannot be determined. Given this limitation, the
ssociation between SAC and cuff blood pressure data may
e inaccurate if the measurements were obtained in an arm
ith concomitant subclavian artery stenosis. However, this
cenario would result in lower SBP readings and likely
nderestimate the association seen in our analysis. The
elationship between SAC and elevated blood pressures
ould also be influenced by the association of SAC with
ncreased arterial stiffness. Specifically, converse to the po-
ential effect of subclavian artery stenosis, increased arterial
tiffness secondary to SAC could elevate SBPs in the af-
ected arm. In addition, we did not obtain ankle-brachial
ndex measurements and therefore cannot comment on the
elationship between lower extremity peripheral arterial
isease and SAC.
The number of individuals with diabetes in the study
as lower than that reported in the general population, and
efinite conclusions about the interaction between diabetes
nd SAC are less certain. The lifetime burden of cigarette
moking (pack/years) was not assessed; therefore, a more
recise relationship between total volume of smoking and
AC could not be determined.
Lastly, the data are limited by a large proportion of
elf-referred individuals; therefore, the findings may not be
pplicable to other populations.
Clinical and epidemiologic significance. The pres-
nt study provides further evidence of the systemic effect of
ypertension, smoking, and aging on vascular calcification.
hese data provide the first evidence that these risk factors
re associated with SAC. We have demonstrated that calci-
cation of this bed is common (affecting about one-third of
ndividuals), even in a cohort with a low rate of established
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have not been given information about the significance of
incidental SAC seen on these scans.
The current study has begun the evaluation of this
vascular bed and sets the stage for further determination of
the prognostic effect of SAC on cardiovascular outcomes. If
a link between SAC and adverse outcomes is found, a
finding of incidental SAC on a CT scan could, for instance,
trigger evaluation of additional vascular beds (coronaries or
carotids) or modify cardiovascular risk. In addition, the
potential relationship between SAC and subclavian artery
stenosis (a clinically relevant disease) is important and will
also need to be explored before the full relevance of SAC
can be elucidated.
Furthermore, it is important to understand the rela-
tionship between SAC and blood pressure, given that
blood pressure is measured in the clinic in the arm. If SAC
is associated with increases or decreases in blood pressure in
the arm, then this could influence the results of cuff pres-
sure measurements and therefore screening for hyperten-
sion.
CONCLUSIONS
The data from the present study demonstrate that the
risk factor profile of SAC—specifically, aging, smoking, and
hypertension—shares similarities with calcification in other
vascular distributions, including the aorta and carotid ar-
teries. However, the presence of SAC may have additional
epidemiologic associations with widening of the PP. These
data suggest a potential link between the presence of SAC
and increased vascular stiffness. The prognosis and clinical
significance of SAC are still poorly defined and require
further study.
We thank Ashwini Jagannath for her assistance in read-
ing the CT scans for SAC.
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